Open Access

Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg‑Ay/J mice and a Taiwanese Han Chinese population

  • Authors:
    • Chi‑Cheng Lu
    • Yng‑Tay Chen
    • Shih‑Yin Chen
    • Yuan‑Man Hsu
    • Chyi‑Chyang Lin
    • Je‑Wei Tsao
    • Yu‑Ning Juan
    • Jai‑Sing Yang
    • Fuu‑Jen Tsai
  • View Affiliations

  • Published online on: May 10, 2018     https://doi.org/10.3892/etm.2018.6152
  • Pages: 185-191
  • Copyright: © Lu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Diabetes mellitus (DM) is a chronic disease. The KK Cg‑Ay/J (KK‑Ay) mouse is an animal model to study type 2 diabetes mellitus (T2D) disease. The present study assessed the expression of hematopoietically expressed homeobox (HHEX) protein in liver tissues of different age groups of mice (6, 16 and 42 weeks) by immunohistochemistry (IHC). The results demonstrated a significant decrease in the percentage of HHEX‑positive cells in KK‑Ay mice as compared with that in KK‑α/α control mice. Furthermore, in Taiwan's Han Chinese population, genotypic and allelic frequency distributions of the rs61862780 single‑nucleotide polymorphism (SNP) in the HHEX gene were investigated. The results demonstrated that in the rs61862780 SNP of the 3'‑untranslated region (UTR) of HHEX, the frequency of the CC genotype was higher in patients (6.0%) than in controls (2.7%), while the TT genotype frequency was about equal. In the same SNP, the frequency of the C allele was higher in patients (21.0%) than in controls (17.3%), while the T allele frequency was about equal. These results may pave the road for exploring the KK‑Ay mouse model and the HHEX SNP rs61862780, which was correlated with the susceptibility to T2D in a Chinese population. Based on these findings, an association of HHEX gene expression with pathological features of T2D was indicated.

Introduction

Diabetes mellitus (DM) is a chronic disease with high prevalence in Taiwan (1,2). DM is characterized by a relative or absolute lack of insulin, resulting in hyperglycaemia (3). Chronic hyperglycaemia leads to a variety of complications such as neuropathy, nephropathy and retinopathy and increased risk of cardiovascular disease (4–7). According to the World Health Organization Global report, 422 million individuals were diagnosed with DM in 2016 (8). In Taiwan, DM was reported to be the fifth leading cause of death in 2015 by the Ministry of Health and Welfare of Taiwan (9). DM has two subtypes, namely type 1 and type 2 DM (10,11). Type 1 DM (T1D) is an autoimmune disease that leads to the destruction of the insulin-producing pancreatic β cells in the islets of Langerhans (12). In children and young adults, T1D is the most commonly diagnosed type of DM. T1D is associated with low endogenous insulin production in affected patients, and insulin supplementation by subcutaneous injection is required (13). The blood glucose levels must be frequently monitored to manage the risk of hypoglycaemia (14). Genetic influences and environmental factors have an important role in disease development (15,16). However, T2D is the most common type of DM in Taiwan. It is most commonly diagnosed in middle-aged adults (17). T2D is associated with insulin resistance, which is a lack of appropriate compensation by the β cells, leading to a relative insulin deficiency (18,19). In the early stage, insulin resistance may be improved by weight reduction and exercise (20). A variety of drugs are available for treating T2D (21,22). Treatment with drugs such as sulphonylureas stimulates insulin production by the β cells (23,24), while that with drugs such as biguanides or metformin reduces hepatic glucose production (25,26), while α-glucosidase inhibitors delay carbohydrate uptake in the gut (27,28), thiazolidinediones improve insulin action (29,30) and as glucagon-like peptide 1 (GLP-1) receptor agonists or dipeptidyl peptidase-4 inhibitors target the GLP-1 axis (31,32). DM represents is a complex disease involving various bodily systems. Thus, animal models should be carefully selected, depending on what aspect of the disease is being investigated (33).

One of the mouse models that has not been extensively examined by the National Institutes of Health-sponsored Animal Models of Diabetic Complications Consortium is the KK Cg-Ay/J (KK-Ay) strain (34,35). The KK-Ay mouse is a typical T2D model, and one of the inbred strains established from Japanese native mice (33,35). Yellow KK-Ay mice carry the yellow obesity gene Ay and develop marked adiposity and DM symptoms in comparison with control black KK-α/α mice (36). This model exhibits marked obesity, glucose intolerance and insulin resistance of peripheral tissue, hyperglycemia, dyslipidemia, hypertension and renal glomerular changes (33,35,36). Furthermore, the pancreatic islets in yellow KK-Ay mice are hypertrophic and de-granulated. This mouse strain also presents with signs of diabetic nephropathy (33,35,36).

T2D is a phenotypically and genetically diverse disease characterized by insulin resistance (22,28). Candidate gene mapping and positional cloning have suggested numerous putative susceptibility variants, but only a few genetic variants leading to T2D have been clearly identified, including transcription-factor-7-like 2 (TCF7L2) and hematopoietically expressed homeobox (HHEX) protein (37–39). The HHEX gene is located on chromosome 10q23.33 and encodes a 270 amino-acid protein (40). HHEX contains the insulin-degrading enzyme (IDE) and kinesin family member 11 (40,41). The HHEX gene encodes a transcription factor involved in hepatic and pancreatic development via the Wnt signal pathway, which is fundamental for cell growth and differentiation (42,43). Numerous studies have identified the HHEX gene polymorphisms of rs1111875 T>C and rs7923837 A>G in T2D patients (38,44,45). A genome-wide scan for association provided evidence that HHEX is an excellent candidate susceptibility gene for T2D, and indicated a significant association of rs1111875 and rs7923837 with T2D (38). Although the association between HHEX polymorphisms and T2D has been well studied in humans, it has remained elusive in KK-Ay mice. A preliminary study by our group clearly demonstrated that HHEX mRNA was downregulated in liver tissues of KK-Ay mice as compared with that in KK-α/α control mice by complementary DNA microarray analysis (unpublished data). The present study focused on investigating the association between HHEX and T2D in KK-Ay mice and in a Han Chinese Population in Taiwan.

Materials and methods

KK-α/α and KK-Ay mice

A total of 5 four-week-old male control KK-α/α mice and 5 four-week-old male KK-Ay mice were obtained from Jackson Laboratories (Bar Harbor, ME, USA), the mice were divided into two groups (5 mice/group). The animals were housed in individual cages and provided lab chow (LabDiet 5k52; St. Louis, MO, USA) and water ad libitum in a room with a constant temperature (22–25°C), relative humidity (50–70%) and photoperiod (12-h light/dark cycle). The study was approved by the Institutional Animal Care and Use Committee of China Medical University (IACUC permit no. 102-217) as previously described (46).

Immunohistochemical (IHC) analysis

IHC was performed on paraffin-embedded liver sections as previously described (46,47). IHC staining for HHEX was performed using a Leica Bond MAX automated immunostainer (Leica Microsystems Inc., Buffalo Grove, IL, USA). Tissue sections (5-µm-thick) were de-waxed, treated with Proteinase K enzyme (cat. no. P2308; Sigma-Aldrich; Merck KGaA, Darmstadt, Germany), followed by blocking with 3% hydrogen peroxide (cat. no. H1009; Sigma-Aldrich; Merck KGaA). The slides were incubated in anti-HHEX (cat. no. GTX84369; GeneTex, Hsinchu, Taiwan) antibodies (1:250 dilution) for 30 min at room temperature, followed by horseradish peroxidase-conjugated rabbit anti-mouse immunoglobulin G secondary antibodies (cat. no. 61-6520; 1:1,000; Thermo Fisher Scientific, Inc., Waltham, MA, USA) for 15 min at 37°C. Chromogen visualization was performed using 3,3′-diaminobenzidine tetrahydrochloride (DAB; cat. no. D12384, Sigma-Aldrich; Merck KGaA) for 5 min at room temperature. The sample was washed with 0.05% Tween 20 in Tris-buffered saline (DAKO, Carpinteria, CA, USA) between all steps.

Patients and sample collection for genotyping

A total of 570 patients diagnosed with T2D by endocrinologist at China Medical University Hospital (Taichung, Taiwan) were recruited between August 2014 and August 2015 for the present study from China Medical University Hospital. To compare the prevalence of polymorphisms in patients with that in a healthy population, the genotype frequency data of 1,700 healthy controls were downloaded from the Taiwan Biobank (https://taiwanview.twbiobank.org.tw/taiwanview/dl.do). The single nucleotide polymorphisms (SNPs) in the target gene were queried from the National Center of Biotechnology Information SNP database (http://www.ncbi.nlm.nih.gov/snp). The SNPs of the genes of interest were obtained and compared between the disease and control groups. Chi-square tests were used to calculate odds ratios and P-values. The study was approved by the ethics committee/Institutional Review Board of China Medical University Hospital (no. CMUH103-REC2-071).

Statistical analysis

The Chi-square test was used to determine statistically significant differences in allele/genotype frequencies of HHEX SNP rs61862780 between the case and control groups. Differences were considered statistically significant when P<0.05. The odds ratios (ORs) with 95% confidence intervals (95% CIs) were calculated for the genotypic and allelic frequencies of the HHEX SNP rs61862780. The statistical analysis was performed using SPSS version 11 (SPSS, Inc., Chicago, IL, USA).

Results

Diabetes-associated features of yellow KK-Ay mouse model

The diabetes-associated features of yellow KK-Ay mice according to the supplier's information and previous studies are listed in Table I (33,34). In the late stage (42 weeks), KK-Ay mice presented with a variety of T2D-like characteristics, including abnormal lipid homeostasis, increase in blood glucose levels, hyperglycemia (>400 mg/dl), glucose intolerance, increased circulating insulin and urine glucose levels, insulin resistance, adipose tissue weight increases, increased susceptibility to weight gain, abnormal morphology of pancreatic islets, renal glomerulus and renal tubules, de-granulated pancreatic β cells, dilated renal tubules, expanded mesangial matrix, increased renal glomerulus basement membrane thickness and hyaline cast present in tubules (2,21,31,33).

Table I.

General characteristics of diabetic features of yellow KK Cg-Ay/J mice according to the supplier.

Table I.

General characteristics of diabetic features of yellow KK Cg-Ay/J mice according to the supplier.

Parameter6 weeks16 weeks42 weeks
Abnormal lipid homeostasis+++
Increase in blood glucose levels++++++
Marked hyperglycemia (400–500 mg/dl)+
Impaired glucose tolerance+++
Increased circulating insulin level++++++
Increased urine glucose level++++++
Insulin resistance+++
Adipose tissue weight increases+++
Increased susceptibility to weight gain++++++
Abnormal pancreatic islet morphology+++
Degranulated pancreatic beta cells++++++
Abnormal renal glomerulus morphology++++++
Abnormal renal tubule morphology++++++
Dilated renal tubules++++++
Expanded mesangial matrix++++++
Increased renal glomerulus basement membrane thickness++++++
Hyaline cast is present in tubules++++++
HHEX protein expression in liver tissues of KK-Ay T2D model mice

KK-α/α mice (control group) and KK-Ay mice (T2D group) were individually sacrificed at 6, 16 and 42 weeks of age, and liver tissues were excised, fixed, embedded and sectioned for IHC staining. As presented in Fig. 1, IHC analysis indicated that the HHEX protein expression in liver tissue was decreased with time. Based on these results, HHEX protein expression in liver tissues of KK-Ay mice (T2D group) was significantly lower than that in KK-α/α mice (control group). In addition, it was demonstrated that DM mice (KK-Ay) grew in the period that relative HHEX protein expression were decreased (Fig. 2). Although KK-α/α mice (control group) grew in the same period HHEX protein expression did not change.

Genotypic and allelic frequency distributions of the rs61862780 SNP in the HHEX gene among Taiwan's Han Chinese population

The genotypic and allelic frequency distributions of the rs61862780 SNP in the HHEX gene located within Chromosome 10q23.3 region (92,708,886 bp) are summarized in Table II. The Hardy-Weinberg model was used to describe and predict genotype and allele frequencies in the study cohort. It was observed that for the rs61862780 (C/T) SNP in the 3′-UTR of HHEX, the frequency of the CC genotype was higher in patients (6.0%) than in controls (2.7%). In addition, the frequency of the CT genotype was higher in patients (30.0%) than in controls (29.2%). In comparison with the TT genotype, the OR of the CC genotype was 2.4 (95% CI=1.51–3.8; P<0.001). The allelic frequency of the C allele was higher in patients (21.0%) than in controls (17.3%). In comparison with the T allele, the OR for the C allele was 1.27 (95% CI=1.08–1.5; P<0.005). It was therefore indicated that the HHEX SNP rs61862780 is associated with the susceptibility to T2D.

Table II.

Genotypic and allelic frequencies in the rs61862780 single nucleotide polymorphism of the 3′ untranslated region of the HHEX gene in patients with T2D (n=570) and controls (n=1,698).

Table II.

Genotypic and allelic frequencies in the rs61862780 single nucleotide polymorphism of the 3′ untranslated region of the HHEX gene in patients with T2D (n=570) and controls (n=1,698).

ParameterPatients with T2D, n (%)Control, n (%)OR (95% CI)P-value
Genotype
  CC34 (6.0)45 (2.7)2.4 (1.51–3.8)a<0.001
  CT171 (30.0)496 (29.2)1.09 (0.89–1.35)
  TT365 (64.0)1,157 (68.1)
Allele frequency
  C239 (21)586 (17.3)1.27 (1.08–1.5)b<0.005
  T901 (79)2,810 (82.7)

a Comparison with the TT genotype

b Comparison with the T-allele frequency. CI, confidence interval; OR, odds ratio; T2D, type 2 diabetes.

Discussion

Numerous animal models of T2D are obese to reflect the human condition where obesity is closely linked to T2D development (33). Two genetic mouse models of T2D exist, namely monogenic models (including Lepob/ob and Leprdb/db mice) and polygenic models (including KK Cg-Ay/J mice) (33). A variety of different polygenic mouse models of obesity, glucose intolerance and diabetes are available, and the variety of genotypes, for example KK Cg-Ay/J mice, which are one of the spontaneous animal models of T2D, might allow for more better modeling of T2D in humans compared with other obesity models (33,34,48). In the present study, KK-Ay mice were used to study the protein expression of HHEX in the liver. The KK-Ay mouse strain is glucose-intolerant, insulin-resistant, dyslipidemic and hypertensive (2,21,31). The complex pathogenesis of T2D in obese and non-obese patients involves genetic and environmental factors (49,50). Genome-wide association studies (GWAS) have indicated an association of T2D with several newly identified genes (51,52). Associations of T2D with common variants in HHEX, hepatocyte nuclear factor 4α, potassium voltage-gated channel subfamily J member 11 (KCNJ11), peroxisome proliferator-activated receptor γ, cyclin dependent kinase inhibitor 2A (CDKN2A)/2B, solute carrier family 30 member 8, cell division cycle 123 (CDC123)/calcium/calmodulin dependent protein kinase ID (CAMK1D), TCF7L2, ATP binding cassette subfamily A member 1 and solute-carrier-family-16-member 11 (SLC16A11) genes have been reported in European, Asian and Latin American populations (53–59). Kong et al (53,60,61) demonstrated associations of SNPs in wolframin ER transmembrane glycoprotein, CDK5 regulatory subunit associated protein 1 like 1, CDKN2A/2B, CDC123/CAMK1D, HHEX, TCF7L2, KCNQ1 and melatonin receptor 1B with T2D in a Chinese population. Sladek et al (62) reported variants of the TCF7L2, SLC30A8 and HHEX genes as novel loci associated with T2D by GWAS analysis in a French population. The present study proved that the frequency of the CC genotype of the rs61862780 (C/T) SNP in the 3′UTR of HHEX was higher in T2D patients than in controls compared with that of the TT genotype. In addition, the allelic frequency of the C allele was higher in patients than in controls compared with that of the T allele, which is in agreement with the previous studies (53,60,61). The HHEX gene regulates cell proliferation and tissue differentiation underlying vascular, hepatic differentiation and forebrain neuro-development (63–65). HHEX is essential for heart (66,67), thyroid (68), hepatic and pancreatic development and is a target of the Wnt signaling pathway (43,69). Decreased levels in HHEX-deficient islets cause disrupted paracrine inhibition of insulin release from β cells (70). HHEX activity has been described in the mouse lung, thyroid and liver. Numerous studies reported associations between HHEX/insulin-degrading enzyme variants (rs1111875) and the insulin secretion response following a glucose load, suggesting that the HHEX gene may influence the T2D risk primarily through an effect on β-cell function (47,71,72). However, to the best of our knowledge, HHEX protein expression has not been previously reported in KK-Ay T2D mice. The present study was the first to demonstrate the role of HHEX in KK-Ay mice. The IHC results were corroborated by results of a complementary DNA microarray analysis of the liver tissues (data not shown), which indicated a significant decrease in the expression of HHEX in KK-Ay mice at 16 and 42 weeks. High insulin levels (hyperinsulinemia) are a major feature of T2D in the early stage, and the pancreas fails to produce sufficient insulin to overcome the insulin resistance; however, failure of β-cell function in the late stages of T2D causes a reduction of insulin secretion (73,74). The present results suggested that downregulation of HHEX expression in the liver may contribute to disrupted paracrine control of insulin secretion in KK-Ay T2D mice at 16 and 42 weeks.

Diabetes is a risk factor of various types of cancer, including colorectal cancer (CRC), as well as breast, bladder, liver and pancreatic cancer (75–77). Ma et al (54) demonstrated that T2D-associated variants of HHEX (rs7923837), TCF7L2 (rs290481) and CDKAL1 (rs7756992) increased the risk of cancer in patients with diabetes. Sun et al (78) also demonstrated that two variants on the T2D susceptibility gene HHEX are associated with the risk of CRC in a Chinese population. Therefore, the factors associated with an increased risk for CRC in T2D patients and the underlying mechanisms still require further study. The time-dependent changes in the protein levels of HHEX in KK-Ay T2D mice are summarized in Fig. 2. The present results demonstrated a downregulation of HHEX protein in the liver of KK-Ay T2D mice and an association of the HHEX SNP rs61862780 with T2D in Taiwanese populations, indicating that loss/mutation of HHEX may have an important role in the pathogenesis of T2D.

Acknowledgements

Not applicable.

Funding

This study was supported by the Biosignature project, Academia Sinica, Taiwan and the China Medical University Hospital (Taichung, Taiwan; grant no. DMR-107-123).

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

CCLu, JSY and FJT conceived and designed the experiments. JWT and YNJ performed the experiments. YTC, SYC, YMH and CCLi analyzed the data. CCLu, JSY and FJT wrote and modified the paper. All authors read and approved the final manuscript.

Ethics approval and consent to participate

The animal experiments were approved by the Institutional Animal Care and Use Committee of China Medical University (IACUC permit no. 102-217). The human experiments were approved by the ethics committee/Institutional Review Board of China Medical University Hospital (no. CMUH103-REC2-071).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Hou WH, Li CY, Chen LH, Wang LY, Kuo KN, Shen HN and Chang MF: Prevalence of hand syndromes among patients with diabetes mellitus in Taiwan: A population-based study. J Diabetes. 9:622–627. 2017. View Article : Google Scholar : PubMed/NCBI

2 

Chen SY, Hsu YM, Lin YJ, Huang YC, Chen CJ, Lin WD, Liao WL, Chen YT, Lin WY, Liu YH, et al: Current concepts regarding developmental mechanisms in diabetic retinopathy in Taiwan. Biomedicine (Taipei). 6:72016. View Article : Google Scholar : PubMed/NCBI

3 

Middleton P, Crowther CA and Simmonds L: Different intensities of glycaemic control for pregnant women with pre-existing diabetes. Cochrane Database Syst Rev: CD008540. 2016. View Article : Google Scholar

4 

Adeshara KA, Diwan AG and Tupe RS: Diabetes and complications: Cellular signaling pathways, current understanding and targeted therapies. Curr Drug Targets. 17:1309–1328. 2016. View Article : Google Scholar : PubMed/NCBI

5 

Zatalia SR and Sanusi H: The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones. 45:141–147. 2013.PubMed/NCBI

6 

Resl M and Clodi M: Diabetes and cardiovascular complications. Wien Med Wochenschr. 160:3–7. 2010.(In German). View Article : Google Scholar : PubMed/NCBI

7 

Hahr AJ and Molitch ME: Diabetes, cardiovascular risk and nephropathy. Cardiol Clin. 28:467–475. 2010. View Article : Google Scholar : PubMed/NCBI

8 

World Health Organization, . Global report on diabetes. WHO; Geneva: 2016, http://www.who.int/diabetes/global-report/en/PubMed/NCBI

9 

Ministry of Health and Welfare: 2015 statistics of causes of deathMinistry of Health and Welfare. Taiwan, R.O.C.: https://www.mohw.gov.tw/cp-3265-30093-2.htmlLast Updated July 18. 2017

10 

Yang X, Xu Z, Zhang C, Cai Z and Zhang J: Metformin, beyond an insulin sensitizer, targeting heart and pancreatic β cells. Biochim Biophys Acta. 1863:1984–1990. 2017. View Article : Google Scholar : PubMed/NCBI

11 

Murillo-Maldonado JM and Riesgo-Escovar JR: Development and diabetes on the fly. Mech Dev. 144:150–155. 2017. View Article : Google Scholar : PubMed/NCBI

12 

Boldison J and Wong FS: Immune and pancreatic β cell interactions in type 1 diabetes. Trends Endocrinol Metab. 27:856–867. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Kesavadev J: Insulin pump therapy in pregnancy. J Pak Med Assoc. 66 9 Suppl 1:S39–S44. 2016.PubMed/NCBI

14 

Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kröger J and Weitgasser R: Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: A multicentre, non-masked, randomised controlled trial. Lancet. 388:2254–2263. 2016. View Article : Google Scholar : PubMed/NCBI

15 

Zou D, Ye Y, Zou N and Yu J: Analysis of risk factors and their interactions in type 2 diabetes mellitus: A cross-sectional survey in Guilin, China. J Diabetes Investig. 8:188–194. 2017. View Article : Google Scholar : PubMed/NCBI

16 

Hotta-Iwamura C and Tarbell KV: Type 1 diabetes genetic susceptibility and dendritic cell function: Potential targets for treatment. J Leukoc Biol. 100:65–80. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Cheng CA, Chien WC, Hsu CY, Lin HC and Chiu HW: Risk analysis of carotid stent from a population-based database in Taiwan. Medicine (Baltimore). 95:e47472016. View Article : Google Scholar : PubMed/NCBI

18 

Sakai S, Tanimoto K, Imbe A, Inaba Y, Shishikura K, Tanimoto Y, Ushiroyama T, Terasaki J and Hanafusa T: Decreased β-cell function is associated with reduced skeletal muscle mass in japanese subjects without diabetes. PLoS One. 11:e01626032016. View Article : Google Scholar : PubMed/NCBI

19 

Rezai S, LoBue S and Henderson CE: Diabetes prevention: Reproductive age women affected by insulin resistance. Womens Health (Lond). 12:427–432. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Arias-Loste MT, Ranchal I, Romero-Gómez M and Crespo J: Irisin, a link among fatty liver disease, physical inactivity and insulin resistance. Int J Mol Sci. 15:23163–23178. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Skliros NP, Vlachopoulos C and Tousoulis D: Treatment of diabetes: Crossing to the other side. Hellenic J Cardiol. 57:304–310. 2016. View Article : Google Scholar : PubMed/NCBI

22 

Marín-Peñalver JJ, Martín-Timón I, Sevillano-Collantes C and Del Cañizo-Gómez FJ: Update on the treatment of type 2 diabetes mellitus. World J Diabetes. 7:354–395. 2016. View Article : Google Scholar : PubMed/NCBI

23 

Nenquin M and Henquin JC: Sulphonylurea receptor-1, sulphonylureas and amplification of insulin secretion by Epac activation in β cells. Diabetes Obes Metab. 18:698–701. 2016. View Article : Google Scholar : PubMed/NCBI

24 

Abdelmoneim AS, Welsh RC, Eurich DT and Simpson SH: Sulfonylurea use is associated with larger infarct size in patients with diabetes and ST-elevation myocardial infarction. Int J Cardiol. 202:126–130. 2016. View Article : Google Scholar : PubMed/NCBI

25 

Winkler G: Metformin-new data for an ‘old’, but efficient, safe and reliable antidiabetic drug. Orv Hetil. 157:882–891. 2016. View Article : Google Scholar : PubMed/NCBI

26 

De Souza A, Khawaja KI, Masud F and Saif MW: Metformin and pancreatic cancer: Is there a role? Cancer Chemother Pharmacol. 77:235–242. 2016. View Article : Google Scholar : PubMed/NCBI

27 

Zhang L, Chen Q, Li L, Kwong JS, Jia P, Zhao P, Wang W, Zhou X, Zhang M and Sun X: Alpha-glucosidase inhibitors and hepatotoxicity in type 2 diabetes: A systematic review and meta-analysis. Sci Rep. 6:326492016. View Article : Google Scholar : PubMed/NCBI

28 

Smith JD, Mills E and Carlisle SE: Treatment of pediatric type 2 diabetes. Ann Pharmacother. 50:768–777. 2016. View Article : Google Scholar : PubMed/NCBI

29 

Ahuja V and Chou CH: Novel therapeutics for diabetes: Uptake, usage trends, and comparative effectiveness. Curr Diab Rep. 16:472016. View Article : Google Scholar : PubMed/NCBI

30 

Salazar JJ, Ennis WJ and Koh TJ: Diabetes medications: Impact on inflammation and wound healing. J Diabetes Complications. 30:746–752. 2016. View Article : Google Scholar : PubMed/NCBI

31 

Bae EJ: DPP-4 inhibitors in diabetic complications: Role of DPP-4 beyond glucose control. Arch Pharm Res. 39:1114–1128. 2016. View Article : Google Scholar : PubMed/NCBI

32 

Bonora E and Cigolini M: DPP-4 inhibitors and cardiovascular disease in type 2 diabetes mellitus. Expectations, observations and perspectives. Nutr Metab Cardiovasc Dis. 26:273–284. 2016. View Article : Google Scholar : PubMed/NCBI

33 

King AJ: The use of animal models in diabetes research. Br J Pharmacol. 166:877–894. 2012. View Article : Google Scholar : PubMed/NCBI

34 

O'Brien SP, Smith M, Ling H, Phillips L, Weber W, Lydon J, Maloney C, Ledbetter S, Arbeeny C and Wawersik S: Glomerulopathy in the KK. Cg-A(y)/J mouse reflects the pathology of diabetic nephropathy. J Diabetes Res. 2013:4989252013. View Article : Google Scholar : PubMed/NCBI

35 

Ikeda H: KK mouse. Diabetes Res Clin Pract. 24 Suppl:S313–S316. 1994. View Article : Google Scholar : PubMed/NCBI

36 

Iwatsuka H, Shino A and Suzuoki Z: General survey of diabetic features of yellow KK mice. Endocrinol Jpn. 17:23–35. 1970. View Article : Google Scholar : PubMed/NCBI

37 

Wang Y, Qiao W, Zhao X and Tao M: Quantitative assessment of the influence of hematopoietically expressed homeobox variant (rs1111875) on type 2 diabetes risk. Mol Genet Metab. 102:194–199. 2011. View Article : Google Scholar : PubMed/NCBI

38 

van Vliet-Ostaptchouk JV, Onland-Moret NC, van Haeften TW, Franke L, Elbers CC, Shiri-Sverdlov R, van der Schouw YT, Hofker MH and Wijmenga C: HHEX gene polymorphisms are associated with type 2 diabetes in the Dutch Breda cohort. Eur J Hum Genet. 16:652–656. 2008. View Article : Google Scholar : PubMed/NCBI

39 

Pechlivanis S, Scherag A, Mühleisen TW, Möhlenkamp S, Horsthemke B, Boes T, Bröcker-Preuss M, Mann K, Erbel R, Jöckel KH, et al: Coronary artery calcification and its relationship to validated genetic variants for diabetes mellitus assessed in the Heinz Nixdorf recall cohort. Arterioscler Thromb Vasc Biol. 30:1867–1872. 2010. View Article : Google Scholar : PubMed/NCBI

40 

Zhao J, Deliard S, Aziz AR and Grant SF: Expression analyses of the genes harbored by the type 2 diabetes and pediatric BMI associated locus on 10q23. BMC Med Genet. 13:892012. View Article : Google Scholar : PubMed/NCBI

41 

Feuk L, McCarthy S, Andersson B, Prince JA and Brookes AJ: Mutation screening of a haplotype block around the insulin degrading enzyme gene and association with Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet. 136B:69–71. 2005. View Article : Google Scholar : PubMed/NCBI

42 

Bort R, Signore M, Tremblay K, Barbera Martinez JP and Zaret KS: Hex homeobox gene controls the transition of the endoderm to a pseudostratified, cell emergent epithelium for liver bud development. Dev Biol. 290:44–56. 2006. View Article : Google Scholar : PubMed/NCBI

43 

Hindy G, Mollet IG, Rukh G, Ericson U and Orho-Melander M: Several type 2 diabetes-associated variants in genes annotated to WNT signaling interact with dietary fiber in relation to incidence of type 2 diabetes. Genes Nutr. 11:62016. View Article : Google Scholar : PubMed/NCBI

44 

Kommoju UJ, Samy SK, Maruda J, Irgam K, Kotla JP, Velaga L and Reddy BM: Association of CDKAL1, CDKN2A/B & HHEX gene polymorphisms with type 2 diabetes mellitus in the population of Hyderabad, India. Indian J Med Res. 143:455–463. 2016. View Article : Google Scholar : PubMed/NCBI

45 

Qian Y, Lu F, Dong M, Lin Y, Li H, Chen J, Shen C, Jin G, Hu Z and Shen H: Genetic variants of IDE-KIF11-HHEX at 10q23.33 associated with type 2 diabetes risk: A fine-mapping study in Chinese population. PLoS One. 7:e350602012. View Article : Google Scholar : PubMed/NCBI

46 

Chen YT, Liao JW, Tsai YC and Tsai FJ: Inhibition of DNA methyltransferase 1 increases nuclear receptor subfamily 4 group A member 1 expression and decreases blood glucose in type 2 diabetes. Oncotarget. 7:39162–39170. 2016.PubMed/NCBI

47 

Steneberg P, Bernardo L, Edfalk S, Lundberg L, Backlund F, Ostenson CG and Edlund H: The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of α-synuclein levels in β-cells. Diabetes. 62:2004–2014. 2013. View Article : Google Scholar : PubMed/NCBI

48 

Asrafuzzaman M, Cao Y, Afroz R, Kamato D, Gray S and Little PJ: Animal models for assessing the impact of natural products on the aetiology and metabolic pathophysiology of Type 2 diabetes. Biomed Pharmacother. 89:1242–1251. 2017. View Article : Google Scholar : PubMed/NCBI

49 

Kaul N and Ali S: Genes, genetics, and environment in Type 2 diabetes: Implication in personalized medicine. DNA Cell Biol. 35:1–12. 2016. View Article : Google Scholar : PubMed/NCBI

50 

Cornelis MC, Zaitlen N, Hu FB, Kraft P and Price AL: Genetic and environmental components of family history in type 2 diabetes. Hum Genet. 134:259–267. 2015. View Article : Google Scholar : PubMed/NCBI

51 

Flannick J and Florez JC: Type 2 diabetes: Genetic data sharing to advance complex disease research. Nat Rev Genet. 17:535–549. 2016. View Article : Google Scholar : PubMed/NCBI

52 

Fuchsberger C, Flannick J, Teslovich TM, Mahajan A, Agarwala V, Gaulton KJ, Ma C, Fontanillas P, Moutsianas L, McCarthy DJ, et al: The genetic architecture of type 2 diabetes. Nature. 536:41–47. 2016. View Article : Google Scholar : PubMed/NCBI

53 

Kong X, Zhang X, Xing X, Zhang B, Hong J and Yang W: The association of Type 2 diabetes loci identified in genome-wide association studies with metabolic syndrome and its components in a chinese population with Type 2 diabetes. PLoS One. 10:e01436072015. View Article : Google Scholar : PubMed/NCBI

54 

Ma RC, So WY, Tam CH, Luk AO, Ho JS, Wang Y, Lam VK, Lee HM, Kong AP, Tong PC, et al: Genetic variants for type 2 diabetes and new-onset cancer in Chinese with type 2 diabetes. Diabetes Res Clin Pract. 103:328–337. 2014. View Article : Google Scholar : PubMed/NCBI

55 

Klimentidis YC, Lemas DJ, Wiener HH, O'Brien DM, Havel PJ, Stanhope KL, Hopkins SE, Tiwari HK and Boyer BB: CDKAL1 and HHEX are associated with type 2 diabetes-related traits among Yup'ik people. J Diabetes. 6:251–259. 2014. View Article : Google Scholar : PubMed/NCBI

56 

Sanghera DK, Ortega L, Han S, Singh J, Ralhan SK, Wander GS, Mehra NK, Mulvihill JJ, Ferrell RE, Nath SK and Kamboh MI: Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet. 9:592008. View Article : Google Scholar : PubMed/NCBI

57 

Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, Erdos MR, Stringham HM, Chines PS, Jackson AU, et al: A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science. 316:1341–1345. 2007. View Article : Google Scholar : PubMed/NCBI

58 

Diabetes Genetics Initiative of Broad Institute of Harvard and MIT, Lund University, and Novartis Institutes of BioMedical Research, . Saxena R, Voight BF, Lyssenko V, Burtt NP, de Bakker PI, Chen H, Roix JJ, Kathiresan S, Hirschhorn JN, et al: Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science. 316:1331–1336. 2007. View Article : Google Scholar : PubMed/NCBI

59 

Malhotra A, Coon H, Feitosa MF, Li WD, North KE, Price RA, Bouchard C, Hunt SC and Wolford JK: American Diabetes Association GENNID Study Group: Meta-analysis of genome-wide linkage studies for quantitative lipid traits in African Americans. Hum Mol Genet. 14:3955–3962. 2005. View Article : Google Scholar : PubMed/NCBI

60 

Kong X, Xing X, Hong J, Zhang X and Yang W: Genetic variants associated with lean and obese type 2 diabetes in a Han Chinese population: A case-control study. Medicine (Baltimore). 95:e38412016. View Article : Google Scholar : PubMed/NCBI

61 

Kong X, Xing X, Hong J, Zhang X and Yang W: Association of a type 2 diabetes genetic risk score with insulin secretion modulated by insulin sensitivity among Chinese Hans. Clin Genet. 91:832–842. 2017. View Article : Google Scholar : PubMed/NCBI

62 

Sladek R, Rocheleau G, Rung J, Dina C, Shen L, Serre D, Boutin P, Vincent D, Belisle A, Hadjadj S, et al: A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature. 445:881–885. 2007. View Article : Google Scholar : PubMed/NCBI

63 

Arterbery AS and Bogue CW: Hhex is necessary for the hepatic differentiation of mouse ES cells and Acts via Vegf signaling. PLoS One. 11:e01468062016. View Article : Google Scholar : PubMed/NCBI

64 

Watanabe H, Takayama K, Inamura M, Tachibana M, Mimura N, Katayama K, Tashiro K, Nagamoto Y, Sakurai F, Kawabata K, et al: HHEX promotes hepatic-lineage specification through the negative regulation of eomesodermin. PLoS One. 9:e907912014. View Article : Google Scholar : PubMed/NCBI

65 

Hunter MP, Wilson CM, Jiang X, Cong R, Vasavada H, Kaestner KH and Bogue CW: The homeobox gene Hhex is essential for proper hepatoblast differentiation and bile duct morphogenesis. Dev Biol. 308:355–367. 2007. View Article : Google Scholar : PubMed/NCBI

66 

Deng XP, Zhao LX, Wang BB, Wang J, Cheng LF, Cheng Z, Suo PS, Li H and Ma X: The HHEX gene is not related to congenital heart disease in 296 Chinese patients. World J Pediatr. 9:278–280. 2013. View Article : Google Scholar : PubMed/NCBI

67 

Foley AC and Mercola M: Heart induction by Wnt antagonists depends on the homeodomain transcription factor Hex. Genes Dev. 19:387–396. 2005. View Article : Google Scholar : PubMed/NCBI

68 

Liu S, Chai J, Zheng G, Li H, Lu D and Ge Y: Screening of HHEX mutations in chinese children with thyroid dysgenesis. J Clin Res Pediatr Endocrinol. 8:21–25. 2016. View Article : Google Scholar : PubMed/NCBI

69 

McLin VA, Rankin SA and Zorn AM: Repression of Wnt/beta-catenin signaling in the anterior endoderm is essential for liver and pancreas development. Development. 134:2207–2217. 2007. View Article : Google Scholar : PubMed/NCBI

70 

Zhang J, McKenna LB, Bogue CW and Kaestner KH: The diabetes gene Hhex maintains δ-cell differentiation and islet function. Genes Dev. 28:829–834. 2014. View Article : Google Scholar : PubMed/NCBI

71 

Rong R, Hanson RL, Ortiz D, Wiedrich C, Kobes S, Knowler WC, Bogardus C and Baier LJ: Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes. 58:478–488. 2009. View Article : Google Scholar : PubMed/NCBI

72 

Moore AF, Jablonski KA, McAteer JB, Saxena R, Pollin TI, Franks PW, Hanson RL, Shuldiner AR, Knowler WC, Altshuler D, et al: Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes. 57:2503–2510. 2008. View Article : Google Scholar : PubMed/NCBI

73 

Chiasson JL: Early insulin use in type 2 diabetes: What are the cons? Diabetes Care. 32 Suppl 2:S270–S274. 2009. View Article : Google Scholar : PubMed/NCBI

74 

Fonseca VA: Defining and characterizing the progression of type 2 diabetes. Diabetes Care. 32 Suppl 2:S151–S156. 2009. View Article : Google Scholar : PubMed/NCBI

75 

Vigneri R, Goldfine ID and Frittitta L: Insulin, insulin receptors, and cancer. J Endocrinol Invest. 39:1365–1376. 2016. View Article : Google Scholar : PubMed/NCBI

76 

de Miguel-Díez J, Muñoz-Rivas N, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Monreal M, Jiménez D, Guijarro R and de Andrés López A: Type 2 diabetes is associated with a higher incidence of hospitalization for pulmonary embolism in Spain: Analysis of hospital discharge data during 2004–2013. Respirology. 21:1277–1284. 2016. View Article : Google Scholar : PubMed/NCBI

77 

Yu F, Guo Y, Wang H, Feng J, Jin Z, Chen Q, Liu Y and He J: Type 2 diabetes mellitus and risk of colorectal adenoma: A meta-analysis of observational studies. BMC Cancer. 16:6422016. View Article : Google Scholar : PubMed/NCBI

78 

Sun R, Liu JP, Gao C, Xiong YY, Li M, Wang YP, Su YW, Lin M, Jiang AL, Xiong LF, et al: Two variants on T2DM susceptible gene HHEX are associated with CRC risk in a Chinese population. Oncotarget. 7:29770–29779. 2016.PubMed/NCBI

Related Articles

Journal Cover

July-2018
Volume 16 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Lu CC, Chen YT, Chen SY, Hsu YM, Lin CC, Tsao JW, Juan YN, Yang JS and Tsai FJ: Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg‑Ay/J mice and a Taiwanese Han Chinese population. Exp Ther Med 16: 185-191, 2018
APA
Lu, C., Chen, Y., Chen, S., Hsu, Y., Lin, C., Tsao, J. ... Tsai, F. (2018). Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg‑Ay/J mice and a Taiwanese Han Chinese population. Experimental and Therapeutic Medicine, 16, 185-191. https://doi.org/10.3892/etm.2018.6152
MLA
Lu, C., Chen, Y., Chen, S., Hsu, Y., Lin, C., Tsao, J., Juan, Y., Yang, J., Tsai, F."Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg‑Ay/J mice and a Taiwanese Han Chinese population". Experimental and Therapeutic Medicine 16.1 (2018): 185-191.
Chicago
Lu, C., Chen, Y., Chen, S., Hsu, Y., Lin, C., Tsao, J., Juan, Y., Yang, J., Tsai, F."Hematopoietically expressed homeobox gene is associated with type 2 diabetes in KK Cg‑Ay/J mice and a Taiwanese Han Chinese population". Experimental and Therapeutic Medicine 16, no. 1 (2018): 185-191. https://doi.org/10.3892/etm.2018.6152